192 related articles for article (PubMed ID: 20186939)
1. Leptospira interrogans icterohaemorrhagiae in a patient with Crohn's disease.
Katsanos KH; Katopodis KP; Kosmidou M; Siamopoulos KC; Tsianos EV
Inflamm Bowel Dis; 2010 Nov; 16(11):1824-5. PubMed ID: 20186939
[No Abstract] [Full Text] [Related]
2. Babesiosis in a patient on infliximab for Crohn's disease.
Cullen G; Sands BE; Yajnik V
Inflamm Bowel Dis; 2010 Aug; 16(8):1269-70. PubMed ID: 19885904
[No Abstract] [Full Text] [Related]
3. Intense muscle aches after cleaning a boat on the Amsterdam canals.
van Sandwijk MS; Boerrigter BG; van Veen SQ; van den Berk GE
Neth J Med; 2013; 71(6):316, 320. PubMed ID: 23956314
[No Abstract] [Full Text] [Related]
4. Long-term durability of infliximab treatment in Crohn's disease and efficacy of dose "escalation" in patients losing response.
Chaparro M; Panes J; García V; Mañosa M; Esteve M; Merino O; Andreu M; Gutierrez A; Gomollón F; Cabriada JL; Montoro MA; Mendoza JL; Nos P; Gisbert JP
J Clin Gastroenterol; 2011 Feb; 45(2):113-8. PubMed ID: 21242747
[TBL] [Abstract][Full Text] [Related]
5. Retinal vein thrombosis after infliximab (Remicade) treatment for Crohn's disease.
Puli SR; Benage DD
Am J Gastroenterol; 2003 Apr; 98(4):939-40. PubMed ID: 12738486
[No Abstract] [Full Text] [Related]
6. [Treatment of Crohn's disease by infliximab. About 20 cases].
Serghini M; Karoui S; Meknini M; Matri S; Kallel L; Fekih M; Boubaker J; Filali A
Tunis Med; 2009 Sep; 87(9):579-82. PubMed ID: 20180377
[TBL] [Abstract][Full Text] [Related]
7. [Adalimumab treatment in infliximab-resistant pediatric patient with Crohn's disease].
Veres G; Putz R; Szabó D; Molnár K; Bodánszky H; Dezsofi A; Arató A
Orv Hetil; 2009 Oct; 150(40):1858-60. PubMed ID: 19789146
[TBL] [Abstract][Full Text] [Related]
8. Anti-TNF therapy for Crohn's disease: a perspective (infliximab is not the drug we have been waiting for).
Shanahan F
Inflamm Bowel Dis; 2000 May; 6(2):137-9. PubMed ID: 10833074
[No Abstract] [Full Text] [Related]
9. Remicade approved for children with Crohn's disease.
FDA Consum; 2006; 40(4):6. PubMed ID: 17245830
[No Abstract] [Full Text] [Related]
10. Infliximab treatment for Crohn's disease.
Conroy CA; Cattell R
Postgrad Med J; 2001 Jul; 77(909):436-40. PubMed ID: 11423591
[No Abstract] [Full Text] [Related]
11. Infliximab as first-line therapy for Crohn's disease is premature.
Greenberg GR
Inflamm Bowel Dis; 2002 Jan; 8(1):60-2; discussion 63-5. PubMed ID: 11837941
[No Abstract] [Full Text] [Related]
12. Infliximab as first-line therapy for severe Crohn's disease?
Cohen RD
Inflamm Bowel Dis; 2002 Jan; 8(1):58-9; discussion 63-5. PubMed ID: 11837940
[No Abstract] [Full Text] [Related]
13. Interstitial pneumonitis after infliximab therapy for Crohn's disease.
Weatherhead M; Masson S; Bourke SJ; Gunn MC; Burns GP
Inflamm Bowel Dis; 2006 May; 12(5):427-8. PubMed ID: 16670533
[No Abstract] [Full Text] [Related]
14. Severe Listeria meningoencephalitis in an infliximab-treated patient with Crohn's disease.
Izbéki F; Nagy F; Szepes Z; Kiss I; Lonovics J; Molnár T
Inflamm Bowel Dis; 2008 Mar; 14(3):429-31. PubMed ID: 17973302
[No Abstract] [Full Text] [Related]
15. [Anti-TNF antibodies in the treatment of inflammatory intestinal stenoses in Crohn's disease].
Holtmann M; Wanitschke R; Helisch A; Bartenstein P; Galle PR; Neurath M
Z Gastroenterol; 2003 Jan; 41(1):11-7. PubMed ID: 12541166
[TBL] [Abstract][Full Text] [Related]
16. Use of infliximab in the treatment of Crohn's disease in children and adolescents.
Hyams JS
J Pediatr Gastroenterol Nutr; 2001 Sep; 33 Suppl 1():S36-9. PubMed ID: 11685974
[No Abstract] [Full Text] [Related]
17. Pericarditis as a complication of infliximab therapy in Crohn's disease.
Burke JP; Kelleher B; Ramadan S; Quinlan M; Sugrue D; O'Donovan MA
Inflamm Bowel Dis; 2008 Mar; 14(3):428-9. PubMed ID: 17924565
[No Abstract] [Full Text] [Related]
18. Complications of infliximab therapy in children and adolescents affected by Crohn's disease.
Diamanti A; Papadatou B; Knafelz D; Gambarara M; Ferretti F; Castro M
Am J Gastroenterol; 2003 Dec; 98(12):2812-3. PubMed ID: 14687847
[No Abstract] [Full Text] [Related]
19. Prolonged duration of response to infliximab in early pediatric Crohn's disease.
Kugathasan S
J Pediatr Gastroenterol Nutr; 2001 Sep; 33 Suppl 1():S40-3. PubMed ID: 11685975
[No Abstract] [Full Text] [Related]
20. Infliximab for the treatment of Crohn's disease: efficacy, safety and pharmacoeconomics.
Feagan BG; Enns R; Fedorak RN; Panaccione R; Paré P; Steinhart AH; Wild G
Can J Clin Pharmacol; 2001; 8(4):188-98. PubMed ID: 11743591
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
